首页> 外文期刊>Journal of Clinical Oncology >Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5 (vol 14, pg 234, 2019)

【24h】

Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5 (vol 14, pg 234, 2019)

机译：临床变量对雌激素受体阳性乳腺癌患者患者预测的临床变量：CTS5（Vol 14，PG 234,2019）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Clinical Oncology》 |2020年第6期|共1页
作者
Dowsett Mitch;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5 (vol 14, pg 234, 2019) [J] . Dowsett Mitch Journal of Clinical Oncology . 2020,第6期

机译：临床变量对雌激素受体阳性乳腺癌患者患者预测的临床变量：CTS5（Vol 14，PG 234,2019）
2. Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5 [J] . Dowsett Mitch, Sestak Ivana, Regan Meredith M., Journal of Clinical Oncology . 2018,第19期

机译：临床变量对雌激素受体阳性乳腺癌患者患者预测预测的临床变量：CTS5
3. The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer [J] . Wakako Tajiri, Hideki Ijichi, Katsumi Takizawa, Breast cancer . 2020,第1期

机译：CTS5在雌激素受体阳性早期乳腺癌后期妇女晚期复发预测中的临床有用性
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Integration of Clinical Variables for the Prediction of Late DistantRecurrence in Patients With Estrogen Receptor–Positive Breast CancerTreated With 5 Years of Endocrine Therapy: CTS5 [O] . Mitch Dowsett, Ivana Sestak, Meredith M. Regan, -1

机译：临床变量的集成用于预测远距离雌激素受体阳性乳腺癌患者的复发经过5年的内分泌治疗：CTS5
6. Prognostic Impact of the Combination of Recurrence Score and Quantitative Estrogen Receptor Expression (ESR1) on Predicting Late Distant Recurrence Risk in Estrogen Receptor–Positive Breast Cancer After 5 Years of Tamoxifen: Results From NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-28 and B-14 [O] . Norman Wolmark, Eleftherios P. Mamounas, Frederick L. Baehner, 2016

机译：复发评分和定量雌激素受体表达（ESR1）组合的预后影响预测雌激素受体阳性乳腺癌晚期遥远的复发风险：NRG肿瘤学/国家外科辅助乳房和肠道项目B-28的结果和B-14

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号